Zurich Cantonal Bank’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$174M Sell
353,363
-10,207
-3% -$5.54M 0.38% 35
2025
Q4
$211M Buy
363,570
+128,443
+55% +$72.6M 0.45% 23
2025
Q3
$114M Buy
235,127
+14,491
+7% +$6.75M 0.26% 66
2025
Q2
$89.5M Sell
220,636
-5,842
-3% -$2.44M 0.22% 82
2025
Q1
$113M Buy
226,478
+4,731
+2% +$2.56M 0.32% 50
2024
Q4
$115M Sell
221,747
-58,544
-21% -$32.2M 0.33% 44
2024
Q3
$173M Sell
280,291
-44,169
-14% -$26.1M 0.52% 26
2024
Q2
$179M Sell
324,460
-51,389
-14% -$29.4M 0.58% 23
2024
Q1
$218M Sell
375,849
-23,383
-6% -$13.1M 0.77% 17
2023
Q4
$212M Buy
399,232
+89,190
+29% +$43.2M 0.81% 17
2023
Q3
$157M Sell
310,042
-23,814
-7% -$12.7M 0.69% 18
2023
Q2
$174M Buy
333,856
+17,491
+6% +$9.44M 0.77% 17
2023
Q1
$182M Sell
316,365
-3,278
-1% -$1.85M 0.89% 14
2022
Q4
$176M Sell
319,643
-32,991
-9% -$17.5M 0.94% 14
2022
Q3
$179M Buy
352,634
+10,761
+3% +$6.02M 1.06% 10
2022
Q2
$186M Buy
341,873
+9,848
+3% +$5.42M 1.09% 11
2022
Q1
$196M Sell
332,025
-22,326
-6% -$12.8M 0.97% 12
2021
Q4
$236M Buy
354,351
+28,801
+9% +$18M 1.14% 13
2021
Q3
$186M Buy
325,550
+22,854
+8% +$12.5M 1.01% 11
2021
Q2
$153M Buy
302,696
+6,222
+2% +$2.94M 0.85% 13
2021
Q1
$135M Buy
296,474
+24,152
+9% +$11.5M 0.8% 14
2020
Q4
$127M Buy
272,322
+21,190
+8% +$9.94M 0.77% 17
2020
Q3
$111M Buy
251,132
+164,360
+189% +$67.9M 0.78% 16
2020
Q2
$31.4M Sell
86,772
-15,308
-15% -$5.13M 0.27% 70
2020
Q1
$28.9M Sell
102,080
-33,367
-25% -$10.5M 0.27% 70
2019
Q4
$44M Buy
135,447
+4,264
+3% +$1.29M 0.34% 54
2019
Q3
$38.2M Buy
131,183
+36,479
+39% +$10.4M 0.32% 62
2019
Q2
$27.8M Buy
94,704
+140
+0.1% +$38.6K 0.24% 81
2019
Q1
$25.9M Buy
94,564
+2,987
+3% +$743K 0.23% 92
2018
Q4
$20.5M Sell
91,577
-60,892
-40% -$14.3M 0.21% 110
2018
Q3
$37.2M Sell
152,469
-47,043
-24% -$10.8M 0.32% 58
2018
Q2
$41.3M Buy
199,512
+1,924
+1% +$408K 0.37% 49
2018
Q1
$40.8M Sell
197,588
-4,957
-2% -$1.04M 0.37% 49
2017
Q4
$38.5M Buy
202,545
+3,654
+2% +$700K 0.34% 51
2017
Q3
$37.6M Sell
198,891
-36,955
-16% -$6.69M 0.35% 58
2017
Q2
$41.1M Buy
235,846
+27,647
+13% +$4.64M 0.41% 47
2017
Q1
$32M Sell
208,199
-23,047
-10% -$3.52M 0.32% 69
2016
Q4
$32.6M Sell
231,246
-6,323
-3% -$932K 0.34% 64
2016
Q3
$37.8M Buy
237,569
+64,844
+38% +$9.99M 0.39% 54
2016
Q2
$25.5M Sell
172,725
-64,324
-27% -$9.49M 0.33% 64
2016
Q1
$33.6M Sell
237,049
-1,455
-0.6% -$195K 0.43% 53
2015
Q4
$33.8M Sell
238,504
-74,690
-24% -$9.96M 0.43% 48
2015
Q3
$38.3M Buy
313,194
+5,086
+2% +$663K 0.54% 38
2015
Q2
$40M Sell
308,108
-8,778
-3% -$1.14M 0.55% 38
2015
Q1
$42.6M Buy
316,886
+278,851
+733% +$35.9M 0.59% 40
2014
Q4
$4.76M Sell
38,035
-10,604
-22% -$1.29M 0.15% 172
2014
Q3
$5.92M Sell
48,639
-2,800
-5% -$340K 0.19% 110
2014
Q2
$6.07M Buy
51,439
+1,601
+3% +$188K 0.18% 126
2014
Q1
$5.99M Buy
49,838
+16,135
+48% +$1.92M 0.19% 119
2013
Q4
$3.75M Buy
33,703
+815
+2% +$81K 0.12% 193
2013
Q3
$3.03M Sell
32,888
-18,677
-36% -$1.69M 0.1% 212
2013
Q2
$4.36M Buy
+51,565
New +$4.29M 0.15% 142

Other funds holding TMO

Zurich Cantonal Bank's TMO Position: Q1 2026 in Review

Zurich Cantonal Bank reduced its Thermo Fisher Scientific (TMO) stake by 2.8% in Q1 2026, selling an estimated $5.54M and leaving 353,363 shares worth $174M. The position accounts for 0.38% of the portfolio, ranked #35.

Zurich Cantonal Bank first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $236M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Zurich Cantonal Bank held 353,363 shares of Thermo Fisher Scientific worth $174M as of Q1 2026.
  • Zurich Cantonal Bank sold 10,207 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.54M.
  • Thermo Fisher Scientific made up 0.38% of Zurich Cantonal Bank's portfolio in Q1 2026, its #35 holding.
  • Zurich Cantonal Bank first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Zurich Cantonal Bank's Thermo Fisher Scientific position peaked at $236M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.